Apogee shareholders elect directors, ratify auditor, approve say-on-pay at 2026 annual meeting

Apogee Therapeutics, Inc.

Director nominees Mark C. McKenna, Jennifer Fox, William Jones elected with >44.9M votes each, broker non-votes 1.8M.
Ratification of Ernst & Young as independent auditor for FY2026: 56.96M for, 1,361 against.
Non-binding advisory vote on named executive officer compensation: 54.32M for, 634k against, 247k abstentions.
All three proposals passed; no material changes to board composition or corporate governance.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Apogee Therapeutics, Inc. shareholders approved Advisory vote on compensation of named executive officers at the 2026-06-09 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2026-06-09

Exact text from the filing

The compensation of our named executive officers as disclosed in the Proxy Statement was approved on a non-binding, advisory basis as follows: Votes For Votes Against Abstentions Broker Non-Votes 54,324,725 633,959 246,567 1,795,532

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Apogee Therapeutics, Inc. shareholders approved Election of Class III directors at the 2026-06-09 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-09

Exact text from the filing

The following Class III director nominees were elected to serve until the 2029 Annual Meeting of Stockholders based upon the following votes: Nominee Votes For Votes Withheld Broker Non-Votes Mark C. McKenna 53,689,547 1,515,704 1,795,532 Jennifer Fox 52,895,552 2,309,699 1,795,532 William (BJ) Jones, Jr. 44,964,804 10,240,447 1,795,532

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Apogee Therapeutics, Inc. shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm at the 2026-06-09 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-09

Exact text from the filing

The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 was ratified as follows: Votes For Votes Against Abstentions 56,960,778 1,361 38,644

View on SEC.gov

1639 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Apogee Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-269650

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.